Streetbeat News

Credit

ULY

Urgently has announced short-term extensions of its term loans to support capital structure improvements and refinancing efforts.

Portfolio Pulse from

February 14, 2025 | 9:30 pm

GNFT

GENFIT has amended the final terms of its 2025 OCEANEs repurchase proposal, including a consent fee for holders of outstanding OCEANEs after repurchase. This move is part of GENFIT's financial strategy to manage its convertible bonds.

Portfolio Pulse from

February 14, 2025 | 9:30 pm

AAAU

The U.S. is sitting on a significant gold reserve, raising questions about its potential to address the national debt problem. However, the feasibility and impact of using gold reserves to fix the debt issue remain uncertain.

Portfolio Pulse from

February 14, 2025 | 7:30 pm

AL

Air Lease Corporation's Q4 2024 earnings and revenues exceeded estimates but showed a year-over-year decline. The decline was primarily due to higher interest expenses resulting from increased composite cost of funds and a higher outstanding debt balance.

Portfolio Pulse from

February 14, 2025 | 3:30 pm

ZCAR

Zoomcar Holdings, Inc. (Nasdaq: ZCAR) reported its fiscal third quarter 2024 results, highlighting a 19% growth in bookings, record repeat user rates, and high-quality host retention. The company is also undergoing debt restructuring.

Portfolio Pulse from

February 14, 2025 | 3:00 pm

BCS

Barclays PLC's Q4 results revealed a 24.3% increase in total income, driven by strong UK and Investment Banking performance. However, concerns about credit headwinds, declining mortgage rates, and rising delinquencies in Barclays UK could impact future performance.

Portfolio Pulse from

February 14, 2025 | 2:15 pm

MNBD

Municipal bonds are expected to perform well in 2025, appealing to risk-averse income investors. This is anticipated even if the Federal Reserve does not lower interest rates.

Portfolio Pulse from

February 14, 2025 | 2:15 pm

SRPT

Sarepta Therapeutics has secured a $600 million senior secured revolving credit facility, enhancing its financial flexibility and balance sheet strength.

Portfolio Pulse from

February 14, 2025 | 1:45 pm

NVS

Novartis is expected to deliver an 11% annual return by 2027, supported by a strong drug pipeline, financials, and strategic cost management. The company reported a 15.1% sales increase and 29% EPS growth in Q4 2024. Shares are undervalued by 11%, offering a 33% cumulative return potential with a 3.5% dividend yield.

Portfolio Pulse from

February 14, 2025 | 12:45 pm

ET

Energy Transfer, a midstream operator, is a strong investment opportunity with a distribution yield nearing 7%. The company plans $5 billion in growth capex for 2025, supported by a favorable regulatory environment and solid BBB credit ratings.

Portfolio Pulse from

February 14, 2025 | 12:45 pm